NIKE Inc. (NKE)

DECK builds momentum with HOKA and UGG growth and global expansion, while NKE faces revenue pressure and China weakness.

Nike's push into the booming outdoor recreation market — which will kick off on Monday with the launch of a new trail running shoe — will test whether it can turn a little-known sub-brand into a meani...

Nike is rebounding with a new CEO, improved tariff clarity, and a focus on core strengths, despite mixed retail sector earnings. Q4 earnings beat expectations, and technical indicators point to a bull...

NKE faces a $1B hit from fading classics but bets on fresh launches and sport-led innovation to spark recovery.

Despite near-term EPS headwinds and China/wholesale uncertainty, I reiterate my Buy rating on Nike for long-term investors. Short-term challenges, including tariffs and negative EPS revisions, are lik...

NKE emphasizes innovation and cultural scale, while SKX expands globally with comfort and value-driven growth.

Nike (NKE) closed the most recent trading day at $76.39, moving 1.05% from the previous trading session.

Knight and his wife are making a record private gift to Oregon Health & Science University amid broader battles over public funding for higher education.

The Knight Foundation said the gift that will be used to shift the scientific approach to cancer treatment, research and patient care outcomes.

Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University's Cancer Institute. The Knight Foundation says it's the single largest donation ever to a U.S. university...